EPISODE · Apr 23, 2026 · 1 MIN
Weight Loss Drugs May Risk Bone Health and Malnutrition
from TheBrief.Health · host TheBrief.Health
Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable populations.
What this episode covers
Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable populations.
NOW PLAYING
Weight Loss Drugs May Risk Bone Health and Malnutrition
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m